Sweden
· Delayed Price · Currency is SEK Xspray Pharma AB Statistics
Total Valuation
STO:XSPRAY has a market cap or net worth of SEK 1.41 billion. The enterprise value is 1.41 billion.
| Market Cap | 1.41B |
| Enterprise Value | 1.41B |
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:XSPRAY has 37.14 million shares outstanding. The number of shares has increased by 20.43% in one year.
| Current Share Class | 37.14M |
| Shares Outstanding | 37.14M |
| Shares Change (YoY) | +20.43% |
| Shares Change (QoQ) | +6.85% |
| Owned by Insiders (%) | 4.46% |
| Owned by Institutions (%) | 40.85% |
| Float | 25.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.43 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.43 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.94 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.24 |
| Quick Ratio | 0.98 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.53 |
| Interest Coverage | -45.14 |
Financial Efficiency
Return on equity (ROE) is -43.14% and return on invested capital (ROIC) is -23.47%.
| Return on Equity (ROE) | -43.14% |
| Return on Assets (ROA) | -22.25% |
| Return on Invested Capital (ROIC) | -23.47% |
| Return on Capital Employed (ROCE) | -42.36% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -10.00M |
| Employee Count | 27 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -142,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.71% in the last 52 weeks. The beta is 0.48, so STO:XSPRAY's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -54.71% |
| 50-Day Moving Average | 32.39 |
| 200-Day Moving Average | 39.43 |
| Relative Strength Index (RSI) | 72.53 |
| Average Volume (20 Days) | 20,291 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -256.82M |
| Pretax Income | -260.22M |
| Net Income | -260.07M |
| EBITDA | -252.63M |
| EBIT | -256.82M |
| Earnings Per Share (EPS) | -7.52 |
Balance Sheet
The company has 125.73 million in cash and 126.96 million in debt, giving a net cash position of -1.23 million or -0.03 per share.
| Cash & Cash Equivalents | 125.73M |
| Total Debt | 126.96M |
| Net Cash | -1.23M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 580.46M |
| Book Value Per Share | 15.63 |
| Working Capital | 31.26M |
Cash Flow
In the last 12 months, operating cash flow was -233.39 million and capital expenditures -4.32 million, giving a free cash flow of -237.70 million.
| Operating Cash Flow | -233.39M |
| Capital Expenditures | -4.32M |
| Free Cash Flow | -237.70M |
| FCF Per Share | -6.40 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:XSPRAY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -20.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -18.43% |
| FCF Yield | -16.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |